Skip to main
UMRX

Unum Therapeutics (UMRX) Market Capitalization Overview

Market Cap: $5.83B as of Feb 19, 2026

$5.83B
$91.24M (1.54%)past month
As of Feb 19, 2026, Unum Therapeutics (UMRX) has a market capitalization of $5.83B. Over the past 30 days, its market cap has increased by 9.27%, while in the last 12 months, it has increased by 7.94%.

Market capitalization represents the total value of Unum Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Unum Therapeutics (UMRX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Unum Therapeutics (UMRX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Unum Therapeutics (UMRX) Market Cap History

DateMarket CapChange
Dec 1, 2025$6.05B+179.20%
Nov 3, 2025$2.17B+9.70%
Oct 1, 2025$1.98B+17.75%
Sep 2, 2025$1.68B-10.23%
Aug 1, 2025$1.87B+127.17%
Jul 1, 2025$822.05M+28.70%
Jun 2, 2025$638.74M-0.36%
May 1, 2025$641.01M-2.76%
Apr 1, 2025$659.20M-17.29%
Mar 3, 2025$796.95M-19.75%
Feb 3, 2025$993.06M+15.26%
Jan 2, 2025$861.61M-17.63%

Unum Therapeutics (UMRX) End of Year Market Cap History

DateMarket CapChange
2026$5.83B+7.94%
2025$5.41B+526.85%
2024$861.61M+70.14%
2023$506.42M-37.32%
2022$807.97M+136.30%
2021$341.93M

FAQs About Unum Therapeutics (UMRX) Market Cap

As of Feb 19, 2026, the market capitalization of Unum Therapeutics (UMRX) is $5.83B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Unum Therapeutics’s market capitalization has decreased by -1.54%, changing from $5.93B to $5.83B as of Feb 19, 2026.

In the last 3 months, Unum Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Unum Therapeutics’s market capitalization increased from $861.61M in January to $5.41B in December, reflecting a 526.85% change.

In the past five years, Unum Therapeutics (UMRX) has had a compound annual growth rate (CAGR) of 73.66% in market capitalization. This means its market cap has grown at an average rate of 73.66% per year.

Unum Therapeutics (UMRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.